Analgesics in the United Arab Emirates is set to demonstrate slower growth in 2026 than observed in the wider Middle East and Africa, with retail value rising by 4% to AED894 million, as economic pressures and evolving health behaviours limit demand. The landscape remains defined by the dominance of systemic analgesics, yet faces mounting competition from preventive health solutions and a rapidly expanding e-commerce channel. As consumers prioritise efficacy, value and prevention, reflected in the success of dual-action products and a shift towards hydration and wellness supplements, brands must innovate around multifunctionality and digital convenience to capture growth in an environment characterised by rising price sensitivity and a stable but highly concentrated competitive environment.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Overview:
Understand the latest market trends and future growth opportunities for the Analgesics industry in United Arab Emirates with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Analgesics industry in United Arab Emirates, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
The Analgesics in United Arab Emirates report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volume and value sizes, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent research methodology, conducted in-country
This report answers:
- What is the market size of Analgesics in United Arab Emirates?
- Which are the leading brands in Analgesics in United Arab Emirates?
- How are products distributed in Analgesics in United Arab Emirates?
- How has the regulatory and operating environment for Analgesics changed in United Arab Emirates?
- How are considerations such as stress, self-medication and shifting consumer lifestyles shaping demand for Analgesics
- How significant are wider health concerns and consumer awareness in determining sales?
- Where is future growth expected to be most dynamic?
Key Data Insights
Panadol's dual-action formula appeals to cost-conscious consumers
Careem's digital delivery expansion boosts online pain relief purchases
Preventive health and hydration solutions intensify competition for pain relief
Chart 1 Value Sales 2021-2031
Chart 2 Value Sales by Category 2026
Preventive health trends to constrain analgesics growth over the forecast period
Topical analgesics to outpace systemic as targeted pain relief gains favour in the UAE
Dual-action and multifunctional products to drive analgesics innovation in the UAE
Chart 1 Forecast Value Sales 2021-2031
Chart 2 Forecast Value Sales by Category 2026-2031
Panadol leverages brand trust and reach to defend GSK Consumer Healthcare's lead
Chart 1 Company Shares 2026
Chart 2 Brand Shares 2026
Pharmacies retains lead in analgesics distribution in the UAE
Pharmacy chains fuel digital delivery and e-commerce surge
Chart 1 Retail Channels 2021-2026
Chart 1 Real GDP Growth 2021-2031
Chart 2 Inflation 2021-2031
Chart 1 Population 2021-2031
Chart 2 Population by Generation 2026
Chart 3 Consumer Expenditure 2021-2031
Country Reports Disclaimer
The following categories and subcategories are included:
Analgesics
-
-
- Adult Acetaminophen
- Adult Aspirin
- Adult Combination Products - Analgesics
- Adult Diclofenac
- Adult Dipyrone
- Adult Ibuprofen
- Adult Ketoprofen
- Adult Naproxen
- Adult OTC Triptans
-
- Paediatric Acetaminophen
- Paediatric Aspirin
- Paediatric Combination Products - Analgesics
- Paediatric Dipyrone
- Paediatric Ibuprofen
- Paediatric Naproxen
-
- Acetaminophen
- Aspirin
- Combination Products - Analgesics
- Diclofenac
- Dipyrone
- Ibuprofen
- Ketoprofen
- Naproxen
- OTC Triptans
-
- Topical Analgesics/Anaesthetic
Analgesics
Analgesics cover systemic and topical pain relievers. Products which include a pain-relief ingredient in addition to another core function are excluded (e.g. a sore throat remedy which includes paracetamol is excluded from the analgesics and instead is included in pharyngeal remedies).
See all of our definitionsWhy buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This report originates from Passport, our Analgesics research and analysis database.
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!